Literature DB >> 15849808

Dynamic expression of pepsinogen C in gastric cancer, precancerous lesions and Helicobacter pylori associated gastric diseases.

Pei-Fang Ning1, Hui-Jie Liu, Yuan Yuan.   

Abstract

AIM: To investigate the relationship between the expression of pepsinogen C (PGC) and gastric cancer, precancerous diseases, and Helicobacter pylori (H pylori) infection.
METHODS: The expression of PGC was determined by immunohistochemistry method in 430 cases of gastric mucosa. H pylori infection was determined by HE staining, PCR and ELISA in 318 specimens.
RESULTS: The positive rate of PGC expression in 54 cases of normal gastric mucosa was 100%. The positive rates of PGC expression in superficial gastritis or gastric ulcer or erosion, atrophic gastritis or gastric dysplasia and gastric cancer decreased significantly in sequence (P<0.05; 100%/89.2% vs 14.3%/15.2% vs 2.4%). The over-expression rate of PGC in group of superficial gastritis with H pylori infection was higher than that in group without H pylori infection (P<0.05; chi2= 0.032 28/33 vs 15/25). The positive rate of PGC expression in group of atrophic gastritis with H pylori infection was lower than that in group without H pylori infection (P<0.01; chi2= 0.003 4/61 vs 9/30), and in dysplasia and gastric cancer.
CONCLUSION: The level of PGC expression has a close relationship with the degree of malignancy of gastric mucosa and development of gastric lesions. There is a relationship between H pylori infection and expression of antigen PGC in gastric mucosa, the positive rate of PGC expression increases in early stage of gastric lesions with H pylori infection such as gastric inflammation and decreases during the late stage such as precancerous diseases and gastric cancer. PGC-negative cases with H pylori-positive gastric lesions should be given special attention.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15849808      PMCID: PMC4305740          DOI: 10.3748/wjg.v11.i17.2545

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  27 in total

1.  Association of Helicobacter pylori infection with atrophic gastritis and intestinal metaplasia.

Authors:  K Ohkuma; M Okada; H Murayama; M Seo; K Maeda; M Kanda; N Okabe
Journal:  J Gastroenterol Hepatol       Date:  2000-10       Impact factor: 4.029

2.  Variation in serum pepsinogens with severity and topography of Helicobacter pylori-associated chronic gastritis in dyspeptic patients referred for endoscopy.

Authors:  K Bodger; J I Wyatt; R V Heatley
Journal:  Helicobacter       Date:  2001-09       Impact factor: 5.753

3.  Ethnic differences in serum pepsinogen levels among Japanese and non-Japanese Brazilian gastric cancer patients and controls.

Authors:  M T Fahey; G S Hamada; I N Nishimoto; L P Kowalski; K Iriya; J J Gama-Rodrigues; S Tsugane
Journal:  Cancer Detect Prev       Date:  2000

4.  Molecular cloning of neonate/infant-specific pepsinogens from rat stomach mucosa and their expressional change during development.

Authors:  T Kageyama; M Ichinose; S Tsukada-Kato; M Omata; Y Narita; A Moriyama; S Yonezawa
Journal:  Biochem Biophys Res Commun       Date:  2000-01-27       Impact factor: 3.575

5.  Helicobacter pylori infection is a major risk factor for gastric carcinoma in young patients.

Authors:  K Haruma; K Komoto; T Kamada; M Ito; Y Kitadai; M Yoshihara; K Sumii; G Kajiyama
Journal:  Scand J Gastroenterol       Date:  2000-03       Impact factor: 2.423

6.  Helicobactor pylori infection is closely associated with telomere reduction in gastric mucosa.

Authors:  Hiroki Kuniyasu; Yasuhiko Kitadai; Hiroshi Mieno; Wataru Yasui
Journal:  Oncology       Date:  2003       Impact factor: 2.935

7.  Relationship between pepsinogen I&II and H. pylori infection considered with grade of atrophy and gastroduodenal diseases.

Authors:  Mikio Karita; Ayumi Noriyasu; Eiko Kosako; Satoshi Teramukai; Satoru Matsumoto
Journal:  Dig Dis Sci       Date:  2003-09       Impact factor: 3.199

8.  Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.

Authors:  Benjamin Chun-Yu Wong; Shiu Kum Lam; Wai Man Wong; Jian Shun Chen; Ting Ting Zheng; Rui E Feng; Kam Chuen Lai; Wayne Hsing Cheng Hu; Siu Tsan Yuen; Suet Yi Leung; Daniel Yee Tak Fong; Joanna Ho; Chi Kong Ching; Jun Shi Chen
Journal:  JAMA       Date:  2004-01-14       Impact factor: 56.272

9.  Somatostatin and D cells in patients with gastritis in the course of Helicobacter pylori eradication: a six-month, follow-up study.

Authors:  Aleksandra Sokic Milutinovic; Vera Todorovic; Tomica Milosavljevic; Marjan Micev; Milan Spuran; Neda Drndarevic
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-07       Impact factor: 2.566

10.  A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia.

Authors:  M Dinis-Ribeiro; C Lopes; A da Costa-Pereira; M Guilherme; J Barbosa; H Lomba-Viana; R Silva; L Moreira-Dias
Journal:  J Clin Pathol       Date:  2004-02       Impact factor: 3.411

View more
  17 in total

1.  Gastric cancer in a Caucasian population: role of pepsinogen C genetic variants.

Authors:  Ana L Pinto-Correia; Hugo Sousa; Maria Fragoso; Luís Moreira-Dias; Carlos Lopes; Rui Medeiros; Mário Dinis-Ribeiro
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

2.  Expression of serum let-7c, let-7i, and let-7f microRNA with its target gene, pepsinogen C, in gastric cancer and precancerous disease.

Authors:  Wen-Jing Liu; Qian Xu; Li-Ping Sun; Qi-Guan Dong; Cai-Yun He; Yuan Yuan
Journal:  Tumour Biol       Date:  2014-12-31

3.  Mitogen-activated protein kinase activator with WD40 repeats (MAWD) and MAWD-binding protein induce cell differentiation in gastric cancer.

Authors:  Dongmei Li; Jun Zhang; Yu Xi; Lei Zhang; Wenmei Li; Jiantao Cui; Rui Xing; Yuanmin Pan; Zemin Pan; Feng Li; Youyong Lu
Journal:  BMC Cancer       Date:  2015-09-15       Impact factor: 4.430

4.  Pepsinogen I and II expressions in situ and their correlations with serum pesignogen levels in gastric cancer and its precancerous disease.

Authors:  Ping Li; Caiyun He; Liping Sun; Nannan Dong; Yuan Yuan
Journal:  BMC Clin Pathol       Date:  2013-09-02

Review 5.  Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach.

Authors:  Mona Zamanian-Azodi; Mostafa Rezaei-Tavirani; Hadi Hasanzadeh; Sara Rahmati Rad; Sona Dalilan
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2015

6.  PGC TagSNP and its interaction with H. pylori and relation with gene expression in susceptibility to gastric carcinogenesis.

Authors:  Cai-Yun He; Li-Ping Sun; Qian Xu; Jing-Wei Liu; Jing-Yi Jiang; Nan-Nan Dong; Yuan Yuan
Journal:  PLoS One       Date:  2014-12-31       Impact factor: 3.240

7.  Identification of PGC-related ncRNAs and their relationship with the clinicopathological features of Gastric Cancer.

Authors:  Han-Xi Ding; Ye-Feng Wu; Qian Xu; Yuan Yuan
Journal:  J Cancer       Date:  2021-05-27       Impact factor: 4.207

8.  Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: a case-control study.

Authors:  Qian Xu; Qi-Guan Dong; Li-Ping Sun; Cai-Yun He; Yuan Yuan
Journal:  BMC Clin Pathol       Date:  2013-03-22

9.  The co-expression of functional gastric proteins in dynamic gastric diseases and its clinical significance.

Authors:  Qian Xu; Li-Ping Sun; Ben-Gang Wang; Jing-Wei Liu; Ping Li; Cai-Yun He; Yuan Yuan
Journal:  BMC Clin Pathol       Date:  2013-08-09

10.  The interaction effects of pri-let-7a-1 rs10739971 with PGC and ERCC6 gene polymorphisms in gastric cancer and atrophic gastritis.

Authors:  Qian Xu; Jing-wei Liu; Cai-yun He; Li-ping Sun; Yue-hua Gong; Jing-Jing Jing; Cheng-zhong Xing; Yuan Yuan
Journal:  PLoS One       Date:  2014-02-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.